Prognostic Relevance of CD200/Btla Deletions in Pediatric Precursor-B Cell Acute Lymphoblastic Leukemia Treated According to the EORTC-CLG 58951 Protocol

被引:0
|
作者
Ghazavi, Farzaneh [1 ]
Lammens, Tim [1 ]
Clappier, Emmanuelle [2 ,3 ]
Suciu, Stefan [4 ]
Caye, Aurelie [2 ,3 ]
Zegrari, Samira [3 ]
Bakkus, Marleen [5 ]
Grardel, Nathalie [6 ]
Benoit, Yves [1 ]
Bertrand, Yves [7 ]
Minckes, Odile [8 ]
Costa, Vitor [9 ]
Ferster, Alina [10 ]
Mazingue, Francoise [11 ]
Plat, Genevieve [12 ]
Plouvier, Emmanuel [13 ]
Poiree, Marilyne [14 ]
Uyttebroeck, Anne [15 ]
Ten Bosch, Jutte Van der Werff [5 ]
Helsmoortel, Hetty [1 ]
Meul, Magali [1 ]
Van Roy, Nadine [1 ]
Philippe, Jan [16 ]
Speleman, Frank [1 ]
Cave, Helsne [2 ,3 ]
Van Vlierberghe, Pieter [1 ]
De Moerloose, Barbara [1 ]
机构
[1] Ghent Univ Hosp, Ghent, Belgium
[2] Univ Paris Diderot, Paris, France
[3] Hop Robert Debre, APHP, F-75019 Paris, France
[4] EORTC Headquarters, Brussels, Belgium
[5] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Brussels, Belgium
[6] INSERM U837, Lille, France
[7] Hosp Civils Lyon, Lyon, France
[8] CHRU, Caen, France
[9] Portuguese Oncol Inst, Oporto, Portugal
[10] HUDERF, Brussels, Belgium
[11] Hop A Calmette, CHR, Lille, France
[12] Childrens Hosp, Toulouse, France
[13] CHRU, Besancon, France
[14] Hop Archet, Nice, France
[15] Univ Hosp Gasthuisberg, Leuven, Belgium
[16] Univ Ghent, B-9000 Ghent, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol
    Ghazavi, Farzaneh
    Clappier, Emmanuelle
    Lammens, Tim
    Suciu, Stefan
    Caye, Aurelie
    Zegrari, Samira
    Bakkus, Marleen
    Grardel, Nathalie
    Benoit, Yves
    Bertrand, Yves
    Minckes, Odile
    Costa, Vitor
    Ferster, Alina
    Mazingue, Francoise
    Plat, Genevieve
    Plouvier, Emmanuel
    Poiree, Marilyne
    Uyttebroeck, Anne
    van der Werff-ten Bosch, Jutte
    Yakouben, Karima
    Helsmoortel, Hetty
    Meul, Magali
    Van Roy, Nadine
    Philippe, Jan
    Speleman, Frank
    Cave, Helene
    Van Vlierberghe, Pieter
    De Moerloose, Barbara
    HAEMATOLOGICA, 2015, 100 (10) : 1311 - 1319
  • [2] Minimal residual disease in children with acute lymphoblastic leukemia treated according to the protocol 58,951 of the EORTC-CLG
    Cavé, H
    Preudhomme, C
    van der Werff, J
    Gaub, MP
    Candon, S
    Waterkeyn, C
    Suciu, S
    Vilmer, E
    LEUKEMIA, 2001, 15 (12) : 2013 - 2014
  • [3] OUTCOME OF CORTICORESITANT PATIENTS TREATED WITH THE PEDIATRIC EORTC 58951 PROTOCOL FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Medhaffar, M.
    Frikha, I.
    Ajmi, N.
    Hdiji, S.
    Lakhal, A.
    Bellaaj, H.
    Kassar, O.
    Kammoun, L.
    Ben Othmen, T.
    Elloumi, M.
    HAEMATOLOGICA, 2012, 97 : 493 - 493
  • [4] Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients
    Aref, Salah
    Azmy, Emad
    El-bakry, Kadry
    Ibrahim, Lobna
    Aziz, Sherin Abdel
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2017, 34 (05) : 275 - 285
  • [5] PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE IN PEDIATRIC PRECURSOR-B ACUTE LYMPHOBLASTIC LEUKEMIA
    Kamel, A.
    El-Sharkawy, N.
    Kandeel, E.
    Moussa, H. S.
    El-Haddad, A.
    HAEMATOLOGICA, 2012, 97 : 483 - 483
  • [6] Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)
    De Moerloose, Barbara
    Suciu, Stefan
    Ferster, Alma
    Mazingue, Francoise
    Sirvent, Nicolas
    Costa, Vitor
    Yakouben, Karima
    Lutz, Patrick
    Uyttebroeck, Anne
    Plantaz, Dominique
    Plat, Genevieve
    Millot, Frederic
    Rohrlich, Pierre
    Poiree, Maryline
    Ten Bosch, Jutte Van der Werff
    Hoyoux, Claire
    Boutard, Patrick
    Cave, Helene
    Girard, Sandrine
    Sirvent, Francisco Bautista
    Benoit, Yves
    Bertrand, Yves
    BLOOD, 2012, 120 (21)
  • [7] PROGNOSTIC IMPACT OF IKZF1 DELETIONS IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA TREATED ACCORDING TO NOPHO PROTOCOLS - THE SWEDISH EXPERIENCE
    Ofverholm, I. Ivanov
    Olsson, L.
    Noren-Nystrom, U.
    Forestier, E.
    Nordlund, J.
    Sjogren, H.
    Golovleva, I.
    Heyman, M.
    Zachariadis, V.
    Nordgren, A.
    Johansson, B.
    Barbany, G.
    HAEMATOLOGICA, 2014, 99 : 9 - 9
  • [8] Prognostic relevance of CD20 in adult B-cell precursor acute lymphoblastic leukemia
    Chang, Hong
    Jiang, Allan
    Brandwein, Joseph
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (06): : 1040 - 1042
  • [9] What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
    Palmi, Chiara
    Valsecchi, Maria Grazia
    Longinotti, Giulia
    Silvestri, Daniela
    Carrino, Valentina
    Conter, Valentino
    Basso, Giuseppe
    Biondi, Andrea
    Te Kronnie, Geertruy
    Cazzaniga, Giovanni
    HAEMATOLOGICA, 2013, 98 (08) : 1226 - 1231
  • [10] IKZF1 Deletions are Independent Prognostic Factor in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia in Russia
    Tsaur, G.
    Druy, A.
    Solodonikov, A.
    Popov, A.
    Shapochnik, A.
    Vlasova, A.
    Vakhonina, L.
    Riger, T.
    Verzhbitskaya, T.
    Olshanskaya, Yu.
    Shorikov, E., V
    Arakaev, O. R.
    Saveliev, L., I
    Fechina, L. G.
    ANNALS OF HEMATOLOGY, 2017, 96 : S79 - S80